The word “catheter” comes from Greek, meaning “to let or send down.” Catheters were used as early as 3,000 B.C. to relieve painful urinary retention. In those times, many materials were used to form a ...

Transurethral resection of the bladder tumor (TURBT) followed by intravesical Bacillus Calmette-Guérin (BCG) immunotherapy is a standard treatment for high-risk non muscle-invasive bladder cancer ...

Zachary Klaassen hosts Luis Salgado to discuss metastasis-directed therapy for low-volume hormone-sensitive prostate cancer. The conversation highlights the challenge of interpreting disease volume in ...

Were you unable to attend 11th ERAS World Congress? Get all of the groundbreaking research, new guidelines, ...

David Morris and Brian Chapin discuss practical management of metastatic hormone-sensitive prostate cancer. The conversation addresses key clinical dilemmas facing urologists and medical oncologists, ...

Integrating PARP Inhibitors in the Treatment of Prostate Cancer: Timing, Combination Approaches, and Beyond BRCA1/2Sent on 12 August 2025 Receive via e-mail ...

The 2025 South Central AUA annual meeting included a session on urothelial cancer, featuring a presentation from Dr. Patrick Burnam discussing long-term outcomes of adjuvant UGN-101 in a real-world ...

The immune checkpoint inhibitor combination regimen has become the initial standard of care for metastatic RCC, given its ...

Dr. Palacios concluded his presentation discussing the role of an intraoperative steep Trendelenburg break during robot-assisted laparoscopic radical prostatectomies with the following take-home ...

Detalimogene voraplasmid is a novel, investigational, non-integrating, non-viral genetic medicine-based immunotherapy carrying a plasmid that simultaneously expresses IL-12 and regulators of RIG-I.

The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a trials in progress presentation from Dr. Yair Lotan discussing a streamlined, patient-centric design of the ...